Vincere Biosciences

Startup

www.vincerebio.com

Summarized by Halo AI

Vincere Biosciences is a biotechnology company developing small-molecule therapeutics that enhance mitophagy to treat age-related diseases, including Parkinson’s and skin aging, by restoring mitochondrial health.

Founded & HQ

Cambridge, MA, USA

Company size

1-10 employees

Funding

~$16.3M

IP status

17 patents filed · 6 grants confirmed

Activity highlights

Awarded a $5 million grant from The Michael J. Fox Foundation in November 2025 to advance its USP30 inhibitors for Parkinson's disease toward clinical trials.

Vincere Biosciences is a privately held biotechnology research company headquartered in Cambridge, Massachusetts. It is dedicated to developing small-molecule therapeutics to address age-related diseases, using a discovery approach that combines computational tools with traditional biology and drug discovery expertise.

AI summary generated on Jun 22, 2026

OpenAlex

For general inquiries

Andy Lee

Chief Business Officer

Is this page yours? Boost its visibility

List technologies, facilities, services, or grant collaboration opportunities.

Vincere Biosciences

For general inquiries

Key links